Catholic Health Initiatives and Accenture Apply Analytics to Identify Health Risks among Patient Populations

Catholic Health Initiatives and Accenture will design and implement information management capabilities across healthcare facilities in 17 states. The effort is expected to help CHI target patient populations to improve care delivery and to better monitor patient health, while streamlining clinical operations for more efficient care management. Additionally, the initiative will focus on enhancing data warehouse capabilities and information management governance.

“This effort will advance our existing data and information management capabilities to better manage the health of populations,” said Evon Holladay, MBA, vice president, Enterprise Intelligence, Catholic Health Initiatives. “By identifying at-risk population groups, such as the uninsured and Medicare recipients, we can provide precise interventions that will improve overall patient care and quality of life.” 

This initiative is an extension of an enterprise-wide analytics strategy that Accenture and Catholic Health Initiatives have developed during the past 12 months. Using Accenture Connected Health Services, the effort will establish a solutions platform that can be applied to future quality measurement programs, including care management, clinical integration, managed care and value-based purchasing initiatives.

“Applying analytics will enable better decision making for improved quality of care and efficiency in clinical operations,” said Kelly Rakowski, managing director for Accenture’s health provider business. “This is crucial for healthcare providers, given the changes instituted through healthcare reform. This initiative will position CHI for future growth by ensuring that it continues to be able to provide consistent, high-quality care while reducing costs.” 

Learn more about Accenture’s Insight Driven Health, our work with healthcare providers and Delivering Public Service for the Future

 

About Catholic Health Initiatives

Catholic Health Initiatives is a national nonprofit health system with headquarters in Englewood, Colo. The faith-based system operates in 17 states and includes 78 hospitals; 40 long-term care, assisted- and residential-living facilities; two community health-services organizations; two accredited nursing colleges; and home health agencies. In fiscal year 2012, CHI provided more than $715 million in charity care and community benefit, including services for the poor, free clinics, education and research. With total annual revenues of more than $10.7 billion and approximately 83,000 employees, CHI ranks as the nation’s second-largest faith-based health system.  www.catholichealthinitiatives.com

 

About Accenture

Accenture is a global management consulting, technology services and outsourcing company, with approximately 261,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$27.9 billion for the fiscal year ended Aug. 31, 2012. Its home page is www.accenture.com.

 

Accenture Connected Health Services

Accenture Connected Health Services combine extensive business and clinical insights to deliver operational models and technology systems – including Electronic Health Records and Health Information Exchanges – that enable patient-centric collaboration through better data access and improved decision making. They also help lower costs and create the foundation for future care-delivery models.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.